Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover

S Lin1, W Wang, G M Wilson

  • 1Laboratory of Biological Chemistry, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.

Insights

Prostaglandin A(2) (PGA(2)) reduces cyclin D1 expression by destabilizing its mRNA in lung cancer cells. This involves AUF1 binding to a specific region in the 3' untranslated region of cyclin D1 mRNA.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Prostaglandin A(2) (PGA(2)) is an experimental chemotherapeutic agent known to reduce cyclin D1 expression and cause growth arrest in various cancer cell lines.
  • The precise molecular mechanisms by which PGA(2) down-regulates cyclin D1 expression remain to be fully elucidated, particularly in non-small-cell lung carcinoma.

Purpose of the Study:

  • To investigate the mechanisms underlying PGA(2)-induced down-regulation of cyclin D1 expression in human non-small-cell lung carcinoma H1299 cells.
  • To identify the specific mRNA elements and protein factors involved in regulating cyclin D1 mRNA stability upon PGA(2) treatment.

Main Methods:

  • Utilized a cyclin D1 promoter-luciferase construct and nuclear run-on assays to assess gene transcription rates.
  • Employed electrophoretic mobility-shift assays (EMSA) with radiolabeled RNA probes to detect protein-RNA interactions.
  • Performed RNA-binding protein cross-linking, antibody supershifting, and immunoprecipitation assays to identify and confirm protein binding.
  • Assessed mRNA stability and expression of reporter genes containing specific cyclin D1 3' untranslated region (UTR) elements in transfected cells.

Main Results:

  • PGA(2) treatment did not affect cyclin D1 gene transcription rates but significantly decreased cyclin D1 mRNA stability.
  • Electrophoretic mobility-shift assays revealed enhanced protein binding to cyclin D1 mRNA in PGA(2)-treated cells, correlating with mRNA loss.
  • Binding activity was localized to a 390-base element (K12) within the cyclin D1 3' UTR.
  • The RNA-binding protein AUF1 was identified as a key factor binding to cyclin D1 mRNA, confirmed by antibody-based assays.
  • Insertion of the K12 element into reporter gene 3' UTRs markedly reduced expression and half-life in PGA(2)-treated cells.

Conclusions:

  • PGA(2) down-regulates cyclin D1 expression primarily by decreasing cyclin D1 mRNA stability, not by affecting transcription.
  • A specific 390-base element in the 3' UTR of cyclin D1 mRNA is crucial for mediating this PGA(2)-induced destabilization.
  • The RNA-binding protein AUF1 plays a significant role in the PGA(2)-mediated decay of cyclin D1 mRNA.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...